This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Louisiana State University and Agricultural & Mechanical College, Bausch Health Americas, Inc., Doheny Eye Institute. Active years: 2004-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 840 
1 out of 1 
1 out of 73 
Years Active: 2004-2023
Title: Innovations by Inventor Jean Jacob
Introduction
Jean Jacob is an accomplished inventor based in New Orleans, LA (US). He holds a total of 3 patents that showcase his contributions to the field of ocular drug delivery and bioengineering.
Latest Patents
One of his latest patents is focused on ocular drug delivery devices. This method involves forming an ocular delivery device by exposing a solid, shaped cellulose polymer to a solution containing an active pharmaceutical ingredient (API) and a solvent. The polymer absorbs a portion of the solution, which includes the API and solvent. The process may also involve removing some of the absorbed solvent by allowing it to evaporate or by drying the polymer. Various cellulose polymers, such as hydroxypropyl cellulose, can be utilized, and a range of APIs, including Cyclosporine, Tobramycin, and Vancomycin, can be incorporated. These ocular delivery devices are designed to treat a variety of eye disorders.
Another significant patent by Jacob is the bioartificial lacrimal gland. This invention features a permeable housing that contains lacrimal epithelial cells. The design includes an outlet that connects the interior of the housing to the exterior, allowing for the potential treatment of conditions related to tear production.
Career Highlights
Jean Jacob has made notable contributions through his work at Louisiana State University and Agricultural & Mechanical College, as well as at the Doheny Eye Institute. His research and innovations have significantly impacted the field of ocular health.
Collaborations
Throughout his career, Jacob has collaborated with esteemed colleagues, including Samuel C. Yiu and Yuri McKee. Their joint efforts have further advanced the research and development of ocular therapies.
Conclusion
Jean Jacob's innovative work in ocular drug delivery and bioengineering has led to significant advancements in the treatment of eye disorders. His patents reflect a commitment to improving patient care through scientific innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile